News

FDA Advisers: iPLEDGE Needs More Tweaking


 

FROM A JOINT MEETING OF THE FDA DRUG SAFETY AND RISK MANAGEMENT AND DERMATOLOGIC AND OPHTHALMIC DRUGS ADVISORY COMMITTEES

Finally, the committee was asked to assess the burden on prescribers. According to data from Mylan, there are 14,444 registered prescribers in the iPLEDGE program, primarily with a specialty in dermatology (10,435, or 72%). Family physicians comprised the next largest group (2,095 prescribers 14%). Internists, ob.gyns., and pediatricians also were prescribers.

Mr. Shamp said that the program had become easier to manage for prescribers—a fact reflected by the declining volume of calls to the iPLEDGE call centers. Currently, there are about 20,000 calls a month, with an average hold time of a minute and an average time per call of just under 5 minutes, he said.

Pages

Recommended Reading

Report: Oncology Drugs Hit Hardest by Shortages
MDedge Internal Medicine
IOM: Safety Improvements Needed in Heath IT
MDedge Internal Medicine
Half of Older Cancer Patients Have Unrecognized Medical Problems
MDedge Internal Medicine
AMA Body to Mount Private Medicare Contracting Campaign
MDedge Internal Medicine
U.S. Insurance Spending Tops OECD
MDedge Internal Medicine
NCQA Launches Accreditation of Accountable Care Organizations
MDedge Internal Medicine
SGR Cuts Loom After Supercommittee Fails
MDedge Internal Medicine
President Obama Nominates New Medicare Chief
MDedge Internal Medicine
Medicare Offers Co-Pay–Free Obesity Counseling
MDedge Internal Medicine
Census Bureau Confirms Huge Growth in Over-65 Population
MDedge Internal Medicine

Related Articles